All Stories

  1. Filtered-sunlight phototherapy for neonatal jaundice in low-resource settings: evidence for action
  2. Disability inclusion for early childhood care and development: the twin-track approach
  3. Filtered-sunlight phototherapy for neonatal hyperbilirubinemia: context matters
  4. Scoping review of evidence-based practice guidelines for the evaluation and care of young children with developmental disabilities in LMIC settings: evidence for action
  5. Filtered-sunlight phototherapy for newborns with moderate-to-severe hyperbilirubinemia: a randomized trial
  6. Advancing early childhood development for children with disabilities and the Global Disability Summit 2025
  7. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
  8. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  9. Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021
  10. Brain health equity and the influence of social determinants across the life cycle
  11. Heliotherapy for neonates with severe-to-hazardous hyperbilirubinemia: a randomized controlled, non-inferiority trial
  12. Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
  13. Development of Measures for d/Deaf and Hard of Hearing Stigma: Introduction to the Special Supplement on Stigma Measurement Tools
  14. Bridging the gaps in health and social equity for disabled children in low‐ and middle‐income countries
  15. Early childhood development strategy for the world’s children with disabilities
  16. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  17. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a syst...
  18. Burden of disease scenarios for 204 countries
  19. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  20. Global Health Trends 1950–2021: Impact of COVID-19 on Mortality and Population Growth
  21. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  22. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
  23. Family-Centered Early Intervention Deaf/Hard of Hearing (FCEI-DHH): Guiding Values
  24. Cerebral palsy in African paediatric populations: A scoping review
  25. Strategies for addressing the needs of children with or at risk of developmental disabilities in early childhood by 2030: a systematic umbrella review
  26. Family-Centered Early Intervention Deaf/Hard of Hearing (FCEI-DHH): Cultural & Global Implications
  27. Family-Centered Early Intervention Deaf/Hard of Hearing (FCEI-DHH): Foundation Principles
  28. Family-Centered Early Intervention Deaf/Hard of Hearing (FCEI-DHH): Structure Principles
  29. Family-Centered Early Intervention Deaf/Hard of Hearing (FCEI-DHH): Support Principles
  30. Family-Centered Early Intervention Deaf/Hard of Hearing (FCEI-DHH): Introduction
  31. Mapping heterogeneity in family planning indicators in Burkina Faso, Kenya, and Nigeria, 2000–2020
  32. Global Challenges After a Global Challenge: Lessons Learned from the COVID-19 Pandemic
  33. Heliotherapy for Neonates with Severe-to-Hazardous Hyperbilirubinaemia: A Randomised Controlled, Unblinded, Non-Inferiority Trial
  34. Estimating vaccine coverage in conflict settings using geospatial methods: a case study in Borno state, Nigeria
  35. Global progress towards early childhood development for children with disabilities, 2013–2023
  36. Neurodiversity and humanism in autism: An LMIC health care setting perspective
  37. Sustainable Development Goals summit 2023 and the global pledge on disability-focused early childhood development
  38. UNICEF and global leadership for disability inclusion in early childhood
  39. Universal research index: An inclusive metric to quantify scientific research output
  40. Global leadership is needed to optimize early childhood development for children with disabilities
  41. Editorial: Optimizing school readiness for children with developmental disabilities
  42. The Nurturing Care Framework and Children With Developmental Disabilities in LMICs
  43. Promoting school readiness in children with developmental disabilities in LMICs
  44. Global prevalence of developmental disabilities in children and adolescents: A systematic umbrella review
  45. Mapping Local Variations and the Determinants of Childhood Stunting in Nigeria
  46. Visibilizando la discapacidad: Mirando el otro lado
  47. Visualizando a deficiência: Vendo o outro lado
  48. Regard sur le handicap: Voir l'autre côté
  49. Disabilities in Early Childhood: A Global Health Perspective
  50. Global investments to optimise the health and wellbeing of children with disabilities: a call to action
  51. Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018
  52. The overlapping burden of the three leading causes of disability and death in sub-Saharan African children
  53. Viewing disability: Seeing the other side
  54. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  55. Revisiting the Role of Pediatricians for Optimal Early Childhood Development in LMICs
  56. Solid Fuel Use and Health in Developing Countries
  57. BMJ Paediatrics Openand the Global South: an open call towards editorial diversity and inclusion
  58. Global and regional prevalence of disabilities among children and adolescents: Analysis of findings from global health databases
  59. Prioritising rehabilitation in early childhood for inclusive education: a call to action
  60. Cerebral palsy and developmental intellectual disability in children younger than 5 years: Findings from the GBD-WHO Rehabilitation Database 2019
  61. Validation of the Decision model of the Burden of Hearing loss Across the Lifespan (DeciBHAL) in Chile, India, and Nigeria
  62. Child health, inclusive education and development
  63. The Role of Parenting Interventions in Optimizing School Readiness for Children With Disabilities in Low and Middle Income Settings
  64. Clarifying Best Practices for Early Childhood Development
  65. Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study
  66. Accelerating progress on early childhood development for children under 5 years with disabilities by 2030
  67. Disability in children: a global problem needing a well-coordinated global action
  68. Global investment to reduce the burden of hearing loss
  69. Heliotherapy for Neonatal Hyperbilirubinemia: Some Clarifications and Update
  70. Revisiting the prevalence and population of children with neurological impairments in sub‐Saharan Africa
  71. Mapping Anemia in Women: Global Trends and Inequality
  72. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019
  73. Dismantling Structural Discrimination in Global Health
  74. Child Mortality Trends and Targets: GBD 2019 Findings
  75. Systemic racism in global health: a personal reflection
  76. Infant and Young Child Feeding Practices among Adolescent Mothers and Associated Factors in India
  77. Setting the record straight on measuring SDG 4.2.1 – Authors' reply
  78. Transforming global health through equity-driven funding
  79. Ear and Hearing Care Workforce: Current Status and its Implications: Erratum
  80. Mapping inequalities in exclusive breastfeeding in low- and middle-income countries, 2000–2018
  81. Subnational mapping of HIV incidence and mortality among individuals aged 15–49 years in sub-Saharan Africa, 2000–18: a modelling study
  82. Beyond pledges: academic journals in high-income countries can do more to decolonise global health
  83. The conundrum of a global tool for early childhood development to monitor SDG indicator 4.2.1
  84. Hearing loss prevalence and years lived with disability
  85. Accountability framework to decolonise global health
  86. Mapping routine measles vaccination in low- and middle-income countries
  87. Five insights from the Global Burden of Disease Study 2019
  88. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019
  89. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  90. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  91. Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17
  92. The global distribution of lymphatic filariasis, 2000–18: a geospatial analysis
  93. Promoting Inclusive Early Childhood Development under the SDG Era
  94. Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17
  95. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  96. Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017
  97. Global Burden of Childhood Epilepsy, Intellectual Disability, and Sensory Impairments
  98. Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017
  99. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3
  100. Infants affected by Rh sensitization: A 2-year Canadian National Surveillance Study
  101. GBD 2016. Occupational Carcinogens Collaborators
  102. Global and regional burden of chronic respiratory disease in 2016 arising from non-infectious airborne occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016
  103. Global and regional burden of disease and injury in 2016 arising from occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016
  104. Mapping child growth failure across low- and middle-income countries
  105. Mapping disparities in education across low- and middle-income countries
  106. Premature mortality in children with developmental disabilities
  107. Mapping 123 million neonatal, infant and child deaths between 2000 and 2017
  108. Hearing loss: rising prevalence and impact
  109. Bolajoko Olusanya: personal challenges, public health
  110. Hearing loss grades and the International classification of functioning, disability and health
  111. Correction to: Regional prevalence and determinants of exclusive breastfeeding in India
  112. Diseases, Injuries, and Risk Factors in Child and Adolescent Health, 1990 to 2017
  113. Department of Error
  114. Regional prevalence and determinants of exclusive breastfeeding in India
  115. Poor data produce poor models: children with developmental disabilities deserve better – Authors' reply
  116. Diarrhoea deaths and disability-adjusted life years attributable to suboptimal breastfeeding practices in Nigeria: findings from the global burden of disease study 2016
  117. Global, regional, and national burden of meningitis, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  118. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
  119. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease ...
  120. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  121. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  122. Measuring progress of the health-related Sustainable Development Goals for 195 countries
  123. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
  124. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
  125. Department of Error
  126. Nurturing care for children with developmental disabilities: a moral imperative for sub-Saharan Africa
  127. Developmental disabilities among children younger than 5 years in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  128. Tuberculosis disease burden and attributable risk factors in Nigeria, 1990–2016
  129. Alcohol use and attributable disease burden in 195
  130. Neonatal hyperbilirubinaemia: a global perspective
  131. TV listening and hearing aids
  132. Measuring performance_Healthcare Access_Quality Index for 195 countries and territories
  133. RE: Global Initiatives for Early Childhood Development Should Be Disability Inclusive
  134. The Contribution of Neonatal Jaundice to Global Child Mortality: Findings From the GBD 2016 Study
  135. Timely sensory stimulation and early childhood development
  136. Burden of severe neonatal jaundice: a systematic review and meta-analysis
  137. Department of Error
  138. Severe neonatal hyperbilirubinaemia is frequently associated with long hospitalisation for emergency care in Nigeria
  139. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016
  140. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
  141. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  142. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  143. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  144. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016
  145. Department of Error
  146. Obligations under global health partnerships in LMICs should be contractual
  147. Maternal detection of neonatal jaundice during birth hospitalization using a novel two-color icterometer
  148. Adolescent health in the Eastern Mediterranean Region: findings from the global burden of disease 2015 study
  149. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015
  150. Child and Adolescent Health From 1990 to 2015
  151. A neurologic dysfunction scoring protocol for jaundiced neonates requiring exchange transfusion
  152. Transcutaneous bilirubin nomograms in African neonates
  153. Department of Error
  154. Global, Regional, and National Levels of Maternal Mortality, 1990–2015
  155. Department of Error
  156. Use of Transcutaneous Bilirubin to Determine the Need for Phototherapy in Resource-Limited Settings
  157. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  158. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  159. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  160. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
  161. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
  162. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  163. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015
  164. Correction to Lancet HIV 2016; 3: e361–87
  165. Differences Between Transcutaneous and Serum Bilirubin Measurements in Black African Neonates
  166. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015
  167. The authors reply
  168. Training pediatric emergency medicine specialists in India
  169. Irradiance Decay in Fluorescent and Light-emitting Diode-based Phototherapy Devices: A Pilot Study
  170. Heliotherapy for Neonatal Hyperbilirubinemia in Southwest, Nigeria: A Baseline Pre-Intervention Study
  171. Aging and Hearing Health: The Life-course Approach
  172. A decision-making tool for exchange transfusions in infants with severe hyperbilirubinemia in resource-limited settings
  173. Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013
  174. Predictors of Repeat Exchange Transfusion for Severe Neonatal Hyperbilirubinemia*
  175. The burden and management of neonatal jaundice in Nigeria: A scoping review of the literature
  176. Facility-based constraints to exchange transfusions for neonatal hyperbilirubinemia in resource-limited settings
  177. 10.1016/S0140-6736(15)60692-4
  178. Revisiting the Criteria for Exchange Transfusion for Severe Neonatal Hyperbilirubinemia in Resource-Limited Settings
  179. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition
  180. Infants at risk of significant hyperbilirubinemia in poorly-resourced countries: evidence from a scoping review
  181. A Randomized Trial of Phototherapy with Filtered Sunlight in African Neonates
  182. Structure, function and five basic needs of the global health research system
  183. Screening for neonatal deafness in resource-poor countries: challenges and solutions
  184. Management of late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings
  185. A modified Bilirubin-induced neurologic dysfunction (BIND-M) algorithm is useful in evaluating severity of jaundice in a resource-limited setting
  186. Prevalence of Congenital Cytomegalovirus Infection in Nigeria
  187. Risk Factors for Severe Neonatal Hyperbilirubinemia in Low and Middle-Income Countries: A Systematic Review and Meta-Analysis
  188. Societal impact of bilirubin-induced hearing impairment in resource-limited nations
  189. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  190. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  191. Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  192. Addressing the burden of neonatal hyperbilirubinaemia in countries with significant glucose-6-phosphate dehydrogenase deficiency
  193. Why is kernicterus still a major cause of death and disability in low-income and middle-income countries?
  194. Maternal satisfaction with a novel filtered-sunlight phototherapy for newborn jaundice in Southwest Nigeria
  195. Newborn health research priorities beyond 2015
  196. Safety and Efficacy of Filtered Sunlight in Treatment of Jaundice in African Neonates
  197. Pattern and predictors of maternal care-seeking practices for severe neonatal jaundice in Nigeria: a multi-centre survey
  198. Letter to the Editor regarding ‘Hearing impairment, severe hyperbilirubinemia and heliotherapy’
  199. The global burden of disabling hearing impairment: a call to action
  200. Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels
  201. Letter to the Editor regarding ‘Investigating the burden of hyperbilirubinemia in resource-constrained settings’
  202. Evaluation of Window-Tinting Films for Sunlight Phototherapy
  203. Phototherapy Device Effectiveness in Nigeria: Irradiance Assessment and Potential for Improvement
  204. Pattern and Characteristics of Growth Faltering in Early Infancy in an Urban Sub-Saharan African Setting
  205. Treatment of neonatal jaundice with filtered sunlight in Nigerian neonates: study protocol of a non-inferiority, randomized controlled trial
  206. Risk of sensorineural hearing loss in infants with abnormal head size
  207. Full-term newborns with normal birthweight requiring special care in a resource-constrained setting
  208. Addressing the needs of adolescent mothers and their offspring in Nigeria: a community-based study
  209. Undernutrition and Hearing Impairment
  210. Paediatricians’ perspectives on global health priorities for newborn care in a developing country: a national survey from Nigeria
  211. Full-term newborns with congenital microcephaly and macrocephaly in Southwest Nigeria
  212. Neonatal hearing screening and intervention in resource-limited settings: an overview
  213. Perinatal Outcomes of Multiple Births in Southwest Nigeria
  214. Pattern of head growth and nutritional status of microcephalic infants at early postnatal assessment in a low-income country
  215. Maternal antecedents of infants with abnormal head sizes in southwest Nigeria: A community-based study
  216. Global and regional hearing impairment prevalence: an analysis of 42 studies in 29 countries
  217. Permanent Hearing Loss among Professional Spice Grinders in an Urban Community in Southwest Nigeria
  218. CHILD SURVIVAL AND CHILD DEVELOPMENT IN DEVELOPING COUNTRIES
  219. Perinatal correlates of delayed childbearing in a developing country
  220. Predictors of growth velocity in early infancy in a resource-poor setting
  221. Priorities for Early Childhood Development in Low-Income Countries
  222. Is home birth a marker for severe malnutrition in early infancy in urban communities of low-income countries?
  223. Highlights of the new WHO Report on Newborn and Infant Hearing Screening and implications for developing countries
  224. Maternal and neonatal profile of late-preterm survivors in a poorly resourced country
  225. Infants Delivered in Maternity Homes Run by Traditional Birth Attendants in Urban Nigeria: A Community-Based Study
  226. Making targeted screening for infant hearing loss an effective option in less developed countries
  227. Perinatal Outcomes Associated with Maternal Hypertensive Disorders of Pregnancy in a Developing Country
  228. Predictors of early-onset permanent hearing loss in malnourished infants in Sub-Saharan Africa
  229. Is discordance in TEOAE and AABR outcomes predictable in newborns?
  230. Surrogate measurements for identifying newborns with low birth weight in a community with predominant non-hospital births
  231. Prevalence, pattern and risk factors for undernutrition in early infancy using the WHO Multicentre Growth Reference: a community-based study
  232. Preference for private hospital-based maternity services in inner-city Lagos, Nigeria: An observational study
  233. Intrauterine growth restriction in a low-income country: Risk factors, adverse perinatal outcomes and correlation with current WHO Multicenter Growth Reference
  234. Ambient noise levels and infant hearing screening programs in developing countries: An observational report
  235. Reducing the burden of severe neonatal jaundice in G6PD-deficient populations in low-income countries: are we doing enough?
  236. Pattern and determinants of BCG immunisation delays in a sub-Saharan African community
  237. Telehealth in audiology: The need and potential to reach underserved communities
  238. Perinatal profile of very low birthweight infants under a universal newborn hearing screening programme in a developing country: A case-control study
  239. Hearing health-care delivery in sub-Saharan Africa – a role for tele-audiology
  240. NON-UPTAKE OF FACILITY-BASED MATERNITY SERVICES IN AN INNER-CITY COMMUNITY IN LAGOS, NIGERIA: AN OBSERVATIONAL STUDY
  241. Is undernutrition a risk factor for sensorineural hearing loss in early infancy?
  242. Predictors of term stillbirths in an inner-city maternity hospital in Lagos, Nigeria
  243. Predictors of Preterm Births and Low Birthweight in an Inner-City Hospital in Sub-Saharan Africa
  244. Maternal and neonatal factors associated with mode of delivery under a universal newborn hearing screening programme in Lagos, Nigeria
  245. Place of birth and characteristics of infants with congenital and early-onset hearing loss in a developing country
  246. Adverse neonatal outcomes associated with trial of labor after previous cesarean delivery in an inner-city hospital in Lagos, Nigeria
  247. Infants with HIV-infected mothers in a universal newborn hearing screening programme in Lagos, Nigeria
  248. Optimising the use of routine immunisation clinics for early childhood development in sub-Saharan Africa
  249. Sensorineural hearing loss in infants with neonatal jaundice in Lagos: a community-based study
  250. Correction
  251. Follow-up default in a hospital-based universal newborn hearing screening programme in a low-income country
  252. Newborns at risk of sensorineural hearing loss in low-income countries
  253. Community-based infant hearing screening in a developing country: parental uptake of follow-up services
  254. Universal infant hearing screening programme in a community with predominant non-hospital births: a three-year experience
  255. Costs and performance of early hearing detection programmes in Lagos, Nigeria
  256. Infants with severe neonatal jaundice in Lagos, Nigeria: incidence, correlates and hearing screening outcomes
  257. Predictors of term stillbirths in an inner-city maternity hospital in Lagos, Nigeria*
  258. Are risk factors for stillbirths in low-income countries associated with sensorineural hearing loss in survivors?
  259. Comment on Baltussen and SmithCost-effectiveness of selected interventions for hearing impairment in Africa and Asia: A mathematical modelling approach
  260. Community-based infant hearing screening for early detection of permanent hearing loss in Lagos, Nigeria: a cross-sectional study
  261. Non-hospital delivery and permanent congenital and early-onset hearing loss in a developing country
  262. The Need for Standardization of Methods for Worldwide Infant Hearing Screening: A Systematic Review
  263. Global Health Priorities for Developing Countries: Some Equity and Ethical considerations
  264. Hospital-based universal newborn hearing screening for early detection of permanent congenital hearing loss in Lagos, Nigeria
  265. Pitfalls in the diagnosis and management of transient synovitis of the hip: a retrospective case-note analysis
  266. Priorities for early hearing detection and intervention in sub-Saharan Africa
  267. Factors associated with auditory neuropathy/dys-synchrony in a developing country
  268. <p>Early hearing detection at immunization clinics in developing countries</p>
  269. A Hundred Horizons: The Indian Ocean in the Age of Global Empire (review)
  270. Correction: Addressing the Global Neglect of Childhood Hearing Impairment in Developing Countries
  271. Addressing the Global Neglect of Childhood Hearing Impairment in Developing Countries
  272. Global burden of childhood hearing impairment and disease control priorities for developing countries
  273. CORRECTION
  274. “The Right Stuff”: The Global Burden of Disease
  275. Progress towards early detection services for infants with hearing loss in developing countries
  276. Promoting effective interventions for neglected health conditions in developing countries
  277. Health priorities for developing countries: importance of non-fatal but disabling conditions
  278. Early detection of infant hearing loss: Current experiences of health professionals in a developing country
  279. Ethical issues in screening for hearing impairment in newborns in developing countries
  280. Adverse perinatal conditions in hearing-impaired children in a developing country
  281. Early hearing detection at immunization clinics in developing countries
  282. Reducing the Burden of Communication Disorders in the Developing World
  283. Revisiting the ten questions questionnaire for developing countries
  284. Stillbirths in sub-Saharan Africa
  285. Globalization of Infant Hearing Screening: The Next Challenge before JCIH?
  286. Communication disorders in Nigerian children
  287. Maternal views on infant hearing loss in a developing country
  288. Letter to the Editors: The burden of neonatal jaundice and sepsis in developing countries
  289. Disabilities, physicians and the millennium development goals
  290. Physician education on infant hearing loss in a developing country
  291. <p>Predictors of hearing loss in school entrants in a developing country</p>
  292. <p>Childhood deafness poses problems in developing countries</p>
  293. Screening for early childhood hearing loss in Nigeria
  294. Can the world's infants with hearing loss wait?
  295. State of the world's children: life beyond survival
  296. Childhood deafness poses problems in developing countries
  297. Infant hearing screening: route to informed choice
  298. Classification of childhood hearing impairment: implications for rehabilitation in developing countries
  299. Polio-vaccination boycott in Nigeria
  300. Corrigendum to “Benefits and challenges of newborn hearing screening for developing countries” [Int. J. Pediatr. Otorhinolaryngol. 68 (2004) 287–305]
  301. Benefits and challenges of newborn hearing screening for developing countries
  302. Self-reported outcomes of aural rehabilitation in a developing country
  303. Hearing impairment in children with impacted cerumen
  304. Early Detection of Hearing Impairment in a Developing Country: What Options?: Identificación temprana de problemas auditivos en países en desarrollo: ¿Qué opciones hay?
  305. Hearing impairment prevention in developing countries: making things happen
  306. The hearing profile of Nigerian school children
  307. West African children in private foster care in City and Hackney